Vitalograph Showcases Advanced Respiratory Diagnostics at NACFC 2025

Vitalograph is proud to announce its participation in the 2025 North American Cystic Fibrosis Conference (NACFC), taking place in Seattle, Washington. The NACF brings together leading researchers, clinicians, and healthcare professionals dedicated to improving the lives of people with cystic fibrosis.

Delegates can find the Vitalograph team at Stand #721, where we will be showcasing our range of respiratory diagnostic solutions designed to support early detection, accurate monitoring, and ongoing management of cystic fibrosis-related lung disease. Our experts will be available throughout the event to discuss innovations in respiratory testing technology and explore how our solutions can help clinicians deliver better outcomes for their patients.

Alongside our comprehensive portfolio of spirometry solutions, at NACFC 2025 we will highlight several cutting-edge solutions, including:

• Oscillometry: offering sensitive, non-invasive assessment of small airway function.

• Portable PFT Solutions: enabling flexible, accessible testing across a variety of clinical environments.

• Lung Clearance Index (LCI): providing an early indicator of lung disease progression.

  Below: Patient performs oscillometry with the tremoflo C100